For Cantrixil, as for all our various other pipeline medicines, this is the next key inflection point for the Company in its quest to become major global medication discovery company. The money we hope to raise in today’s Placement and Rights Issue offerings are intended to take the Company compared to that next key inflection stage.’.. Cantrixil medication granted FDA Orphan Drug Designation for treatment of ovarian cancer US-Australian drug discovery firm, Novogen, announced that its subsidiary jv business with Yale University today, CanTx, Inc, today received notification from the U has.S. Food and Medication Administration that its chemotherapy candidate drug, Cantrixil, has been granted Orphan Medication Designation for ovarian tumor. Orphan Drug Designation can be an important development for any experimental medication and offers been instigated in several territories including the U.S, Europe and Australia to encourage the advancement of drugs for clinical indications that do not have a high incidence.Filed matches in the U.S. District Courtroom for the District of Delaware to avoid Barr from proceeding with the commercialization of its item. This step formally initiates the patent problem process beneath the Hatch-Waxman Act. Prevacid SoluTab experienced annual sales of around $428 million in the U.S., predicated on IMS product sales data for the 12-month period closing March 2008.. Costs Gates reflects on Global Vaccine Summit in basis blog This week I'm likely to Abu Dhabi to wait the Global Vaccine Summit to celebrate the tremendous improvement the world has manufactured in closing polio and immunizing kids, Bill Gates, co-seat of the Costs & Melinda Gates Base, writes in the basis's Impatient Optimists blog page.